Also, in our study, although validations studies are required, the in vivo pilot study evidenced that cells pre-demethylated with the CRISPR-peptide-dCas9-TET1-based system tend to behave as normal cells, since they do not exhibit a histological cancer phenotype, grow slowly and form smaller tumors in mice when compared to negative controls. The gene discussed is TET1; the disease is cancer.